Volume29,?Issue14, March 7, 2023, e202203970
期刊：Chemistry A European Journal
作者：Harsh S. Shah,?Dr. Jiuchuang Yuan,?Dr. Tian Xie,?Dr. Zhuocen Yang,?Dr. Chao Chang,?Dr. Chandler Greenwell,?Dr. Qun Zeng,?Dr. GuangXu Sun,?Brandon N. Read,?Timothy S. Wilson,?Dr. Henry U. Valle,?Dr. Shanming Kuang,?Dr. Jian Wang,?Dr. Sivakumar Sekharan,?Dr. Jessica F. Bruhn
時間：2023-02-06
Establishing the absolute configuration of chiral active pharmaceutical ingredients (APIs) is of great importance. Single crystal X-ray diffraction (scXRD) has traditionally been the method of choice for such analysis, but scXRD requires the growth of large crystals, which can be challenging. Here, we present a method for determining absolute configuration that does not rely on the growth of large crystals. By examining microcrystals formed with chiral probes (small chiral compounds such as amino acids), absolute configuration can be unambiguously determined by microcrystal electron diffraction (MicroED). Our streamlined method employs three steps: (1) virtual screening to identify promising chiral probes, (2) experimental cocrystal screening and (3) structure determination by MicroED and absolute configuration assignment. We successfully applied this method to analyze two chiral API molecules currently on the market for which scXRD was not used to determine absolute configuration.
